Objective: Regeneration of bone defects remains a challenge for maxillofacial and reparative surgeons. The purpose of this histological study was to assess the osteogenic potential of octacalcium phosphate (OCP) and bone matrix gelatin (BMG) alone and in combination in artificially created mandibular bone defects in rats. The quality of the newly formed bone was also evaluated.
Introduction
Regeneration of bone defects caused by trauma, infection, or resection of bone tumors remains a challenge in orthopedic and maxillofacial reconstructive surgeries. Autogenous bone grafts are the gold standard of treatment for small defects. However, due to limited quantity, they cannot be used for large defects and biocompatible bone substitutes may be applied instead [1, 2] . A group of synthetic bone substitutes have osteoinductive properties [3] [4] [5] while another group of these materials are osteoconductive and serve as a carrier for preservation and gradual release of bone morphogenetic proteins(BMPs) [6, 7] .
Calcium phosphate derivatives are among the most commonly used synthetic biomaterials for hard tissue regeneration [8] . These materials are also categorized into different groups depending on the ratio of calcium/phosphate in their composition. They highly resemble the natural mineral content of bone and tooth in terms of physical and chemical properties [9] . Different compositions of calcium phosphate materials have variable potential for regeneration of bone defects and some of them only serve as a carrier for osteoconductive proteins [7, 10, 11] . Some others are both osteoconductive and osteoinductive when placed adjacent to bone defects [12, 13] . Octacalcium phosphate (OCP) has both osteoconductive and osteoinductive properties and is believed to be the direct precursor of hydroxyapatite. This material, compared to other calcium phosphate derivatives, has higher potential for both osteoinduction and osteoconduction. It is gradually absorbed and replaced by the newly formed bone [14, 15] . Based on the literature, OCP has shown promising results for healing bone defects when used alone [16] or in combination with biomaterials such as Bone Matrix Gelatin (BMG) or transforming growth factor beta (TGF-β) [17, 18] .
On the other hand, successful healing of bone defects reported after BMG implantation has encouraged researchers to use this material as a synthetic alternative to autogenous bone grafts [19, 20] . Bone matrix gelatin contains type I collagen as well as a high protein content including Bone Morphogenetic Proteins (BMPs), which induce the differentiation of mesenchymal cells to osteoblasts at the site of bone defects [21] . The interaction of BMPs with most calcium phosphate derivatives has yielded favorable results in clinical applications [17, 22, 23] .
We aimed to assess the osteogenic potential of BMG and OCP implanted alone or in combination in mandibular bone defects of rats. The quality of the newly formed bone was also evaluated.
Materials and Methods

A. Preparation of materials:
Synthetic OCP was prepared following the methods previously described [24, 25] . The sieved granules (particle size of 300-500 μm) of OCP, obtained from dried OCP, were sterilized by heating at 120ºC for 2 hours. A previous study showed that such heating does not affect physical properties such as the crystalline structure or specific surface area of OCP granules [26, 27] . Bone matrix gelatin (BMG) was prepared using the method previously described by urist et al. [28] which was modified by the method of Wei-Qi Yan et al. [3] . Briefly, diaphyseal shafts of femora and tibiae from 6-week-old male Sprague dawley rats were cut into chips. Liquid nitrogen was used to freeze bone shafts after their removal and while they were being cut into chips to avoid possible denaturation of proteins, the bone chips were extracted in chloroform-methanol (1:1) for 4 hours at 25 °C, demineralized in 0.6 N of hydrochloric acid at 4 °C for 72 hours, and gelatinized in 6 M of lithium chloride at 2 °C for 24 hours. The bone chips then were auto digested at 37 °C for 48 hours in phosphate buffer (pH 7.4) with 10 mM of sodium azide and 5 mM of iodoacetic acid as a protease inhibitor. The bone chips then were pulverized with a sample chamber and sifted. Particles sized 75-500 µm were collected by the testing sieve, lyophilized, 
C. Surgical procedure and implantation of materials:
Animals were randomly divided into four groups as described above and anesthetized by intraperitoneal injection of 60 mg/kg ketamine hydrochloride (Ketalar, Trustech Pharma Care, Bayern, Germany) and 20 mg/mL xylazine (Pantex Holland B.V., Duizel, Netherland) in 2/1 ratio. Diethyl ether was used for anesthesia maintenance. After the induction of general anesthesia, the animals were fixed on the operating table in a supine position. The respective area on the body of the mandible was shaved and disinfected using 10% Betadine (Toliddarou, Tehran, Iran). During the operation, corneal dryness was prevented using Bactimide® eye drop (Toliddarou, Tehran, Iran). Using a sterile surgical scalpel, a 1.5 cm incision was made on both sides of the mandible and a full-thickness periosteal flap was elevated. Using a dental drill, a defect measuring 3 mm in diameter and 2 mm in depth was drilled in the mandible close to the alveolar crest (in-between the first molar and canine teeth) under copious irrigation with cold saline solution.
In the first experimental group, 6 mg of OCP (previously prepared and packed) was implanted at the site. In the second experimental group, 6 mg of BMG and in the third experimental group, 6 mg of OCP/BMG with a ¼ ratio were implanted in defects. After implantation of the materials, the defects in all experimental groups were covered with Surgicel (Altaylar, Medical, Ankara, Turkey) to prevent the spread of implanted particles. Defects were left empty in the control group and were only covered with Surgicel. The skin and the underlying connective tissue at the surgical site were sutured in two layers using a 4/0 absorbable chromic suture (catgut, Wei Gao Group Kanglida Medical Products Co, LTD. Heze, China) and disinfected. After completion of the operation and recovery of the rats from anesthesia, they were transferred to hygienic cages and kept there until sacrifice at the end of the time table.
D. Harvesting tissue samples:
In all experimental and control groups, tissue samples were harvested at seven, 14, and 21 days (from six rats sacrificed at each time point) to prepare histological sections. At the mentioned time points, general anesthesia was induced by intraperitoneal injection of ketamine hydrochloride. The chest was opened and 10% buffered formalin (fixative) was perfused through the heart to achieve in situ fixation of tissues. The respective area along with a margin of host bone was resected and stored in 10% buffered formalin at room temperature for one week for complete fixation. Next, the tissue specimens were rinsed with cold distilled water for several times and decalcified by immersion in a decalcifying solution containing 10% formic acid, 2.9% citric acid, and 1.8% trisodium citrate dihydrate at room temperature for four weeks [14] . The tissue specimens were routinely prepared and 5μ serial sections were made from paraffinembedded tissue blocks. The desired sections were subjected to H & E staining for evaluation under light microscopy (Zeiss, Carl Zeiss Microscopy GmbH. Goettingen, Germany).
E. Histological evaluation:
Histological analysis of stained specimens was done blindly under a light microscope by a histologist who was blinded to the type of bone substitutes used. Photomicrographs were taken using a photomicroscope (Leica DM 500, Leica Microsystems, GmbH. Wetzler, Germany) at seven, 14, and 21 days of experiment. These cells probably open the path by absorbing the implanted particles and allow for the penetration of pre-osteoblasts and initiation of bone matrix deposition (Figure 2d ).
BMG group:
First week (seven days): The implanted BMG particles were seen as distinct eosinophilic masses at the defect area. The defect margin and the central area (full of BMG particles of variable sizes)
were clearly visible. The spaces in-between BMG particles had been filled with a relatively dense fibrous connective tissue. Cellularity of the connective tissue was greater adjacent to the BMG particles compared to farther areas. The staining of cellular masses was also different at different sites. Connective tissue had penetrated into the matrix porosities in-between BMG particles, dividing each mass into smaller pieces. These gaps appeared to be indicative of initiation of cell differentiation within each particle because the orientation of these cells in BMG gaps was similar to their orientation on the surface of primary particles (Figure 3a) . In one specimen in this group, osteoblasts along with deposited osteoid material were clearly visible at the margins (host bone) and a basophilic line clearly separated the osteoid material from the host bone (Figure 3b ).
Second week (14 days):
Evidence of inflammatory infiltration still existed. Defect margins were clearly visible. The connective tissue had become more organized and filled the gaps in-between BMG particles. Some implanted particles had been covered with differentiated osteoblasts; these osteoblasts had clearly adhered to these particles. Smaller particles had allowed better invasion of blood vessels and connective tissue into them showing evident signs of cell differentiation. The osteogenic potential was more evident in smaller particles compared to large ones with no such penetration. Signs of intramembranous ossification were seen close to the defect margin and adjacent to the host bone. This pattern was less visible at the center of the defect. A basophilic line separated the newly formed bone from the host bone (Figure 3c ). In some specimens in this group, chondroblast-like cells were seen at the center of defect and over some of the BMG particles and a cartilaginous-like tissue was noted in this area (figure not shown).
Third week (21 days):
Similar to the second week, a distinct basophilic line separated the newly formed bone from the host bone at the margins of defects; the only difference was that the newly formed bone highly resembled the host bone and had filled a larger part of the defect to a greater depth. Primary osteon pattern was clearly visible in this group and initiation of the remodeling of bone trabecula was clearly seen (Figure 3d ). At the central areas, the connective tissue was well organized and most BMG particles had been phagocytosed by the multinucleated giant cells. In terms of staining properties, the newly formed bone showed high resemblance to the host bone 
Similar to previous time points, areas at the periphery of the defect and close to host bone showed signs of better osteoblastic differentiation, initiation of osteogenesis and deposition of bone matrix compared to the central areas. The morphology and characteristics of the connective tissue filling the gaps between the implanted particles were similar to the findings at earlier time points. The only difference was that higher cell differentiation was noted adjacent to OCP particles and penetration of connective tissue into BMG particles had increased.
From staining point of view, the organized newly formed bone showed an eosinophilic pattern similar of ECM to the host bone (Figure 4d ).
Discussion
The efficacy of synthetic bone substitutes alone or in combination for bone regeneration has been evaluated in many previous studies [1, 14, 21] . The current study sought to assess the osteogenic potential of BMG and OCP implanted alone and in combination in artificially created bone defects in the mandible of rats. The osteoinductive and osteoconductive properties of these materials were investigated as well. In other words, we tried to combine the osteoinductive properties of BMG with the osteoinductive and osteoconductive properties of OCP to benefit from their synergistic properties and enhance mandibular bone regeneration. The results showed that implantation of OCP at the site of bone defects induced intramembranous (woven) bone formation. Inflammatory cell infiltrates were noted around the OCP particles, surrounded by an organic matrix. This indicated host response to OCP. Kamakura and colleagues reported similar reaction to OCP implantation at the site of defects created on the parietal bone [16] . At three weeks, bone trabecula with an irregular pattern were seen at the defect site in the OCP group in our study. Osteoblasts were noted on the surface and osteocytes were clearly seen at the center of bone trabecula, which were indicative of the organization of the newly formed bone trabecula and their remodeling. Most researchers have reported this finding eight weeks following OCP implantation [25, 29] .
The mechanism of osteoinduction by the implanted OCP particles at the site of mandibular bone
defects has yet to be fully elucidated and their biological properties responsible for induction and progression of bone formation are not known either. Suzuki and co-workers believe that the glycoconjugates present in the tissue accumulated over and around the OCP particles, play a role in osteogenesis [25] . In another study, Suzuki and colleagues [14] stated that the biological properties and the role of OCP in stimulating bone formation are similar to those of TGF-β. He added that bioactive factors such as TGF-β are present in the tissues or tissue fluids accumulated around and over the OCP particles and these factors may be responsible for osteoblastic differentiation, new bone formation and chemotaxis of osteoclasts for bone remodeling. Sasano and co-workers [30] reported that the biological properties of OCP in terms of osteoinduction and osteoconduction were comparable to those of prostaglandin E1. They explained that prostaglandin E1 accumulates in the tissues and tissue fluids surrounding the OCP particles.
Release of prostaglandin E1 may continue for as long as the OCP particles are present at the site, enhancing osteoblastic differentiation. Our results showed that the first step for osteogenesis is induced by the host bone at the most peripheral areas of defect and then gradually extends towards the center.
We found that signs of intramembranous bone formation were evident at the defect margins in the BMG group in the second week following implantation. The timing of new bone formation in this group was similar to the findings of a previous study [31] . On the other hand, appearance of osteoblasts and formation of bone tissue occurred sooner than the cartilaginous tissue and the amount of the new bone formed directly due to osteoblastic differentiation was greater than the amount of bone formed by replacement of residual spaces following destruction and re-absorption of cartilaginous tissue. Thus, it may be stated that cartilaginous tissue played an insignificant role in osteogenesis in the defects, and formation of new bone was mainly the direct result of osteoblastic differentiation. This finding was in agreement with the results of Wang and colleagues [32] , who reported intramembranous ossification following implantation of demineralized bone matrix (DBM) in the cranial region. Thus, it can be concluded that in contrast to endochondral ossification, which occurs following implantation of DBM subcutaneously, intramuscularly or in defects of long bones, implantation of BMG particles in mandibular bone defects of rat results in direct proliferation and differentiation of mesenchymal cells to osteoblasts and consequent induction of new bone formation. It appears that the initiation of osteogenesis was delayed in the BMG group in our study but it was accelerated over time.
In the OCP/BMG group in the current study, a significant inflammatory reaction was noted in the first week following implantation. Mesenchymal cells had differentiated into osteoblast-like cells and covered the defect surface in a regular and orderly fashion. Osteoinduction in this group was greater at the margins compared to the center of defects in the second week. In the third week, new bone formation significantly increased and the amount of BMG particles absorbed was higher than OCP particles. High osteogenesis in this group may be partly because of the delayed absorption of OCP particles, since they induce the release of BMPs from the surrounding tissues and particularly the traumatized bone [17] . Besides, studies similar to this one must be carried out using additional radiographic and histomorphological evaluations in order to provide the necessary tools to allow for qualitative and quantitative comparisons among these materials.
Conclusion
The present study showed that implantation of OCP and BMG particles alone and in combination enhanced the regeneration of bone defects. Combination of OCP/BMG had greater potential for inducing osteoblastic differentiation and new bone formation compared to the application of OCP or BMG per se. It is probable or assumable that using a combination of osteoinductive and osteoconductive materials may be clinically beneficial to enhance regeneration of large bone defects. 
